Based on Zhang Jingdong (εΌ ζ―δΈ), Value Discovery (δ»·εΌεη°) (2019)
Zhang Jingdong's Value Discovery presents a systematic, practitioner-oriented framework for identifying undervalued stocks in the Chinese A-share market through rigorous fundamental analysis. The book rejects both speculative momentum chasing and passive index-hugging in favor of a disciplined, bottom-up process that treats every stock purchase as acquiring a fractional ownership stake in a real business.
The A-share market is structurally inefficient. Information asymmetry, retail sentiment dominance, policy-driven volatility, and short-term performance pressure on institutional managers create persistent mispricings. A patient investor who develops the skill to estimate intrinsic value β and the temperament to act on discrepancies between price and value β can compound wealth at rates far exceeding the market average.
Zhang organizes the entire investment workflow into five sequential stages:
Zhang identifies four structural reasons why value investing is particularly rewarding in the Chinese market:
Intrinsic value is the present value of all future cash flows that a business will generate for its owners, discounted at an appropriate rate that reflects the risk and opportunity cost of capital. It is an estimate β a range, not a point β and it exists independently of the current market price.
Zhang decomposes intrinsic value into three measurable components:
| Pillar | Definition | Primary Metric |
|---|---|---|
| Asset Value | What the business owns, net of obligations | Net Asset Value (NAV) |
| Earnings Power Value | What the business earns in a normalized, steady state | Normalized EPS x Multiple |
| Growth Value | Additional value from reinvesting at above-cost-of-capital | DCF of incremental FCF |
Not all value components carry equal certainty:
Certainty Level:
HIGH ββββββββββββββββββββ Asset Value
ββββββββββββββββ Earnings Power Value
LOW ββββββββββββ Growth Value
Rule: Never pay primarily for growth value. A sound investment should be justified by asset value and earnings power alone, with growth as a free option.
Zhang emphasizes the absolute distinction between value and price:
Zhang insists on using multiple valuation methods and triangulating. No single method is sufficient; each has blind spots. The investor should seek convergence across approaches.
The most theoretically rigorous approach, but also the most assumption-sensitive.
Formula:
Intrinsic Value = Sum(FCF_t / (1 + r)^t) + Terminal Value / (1 + r)^n
Where:
FCF_t = Free cash flow in year t
r = Weighted average cost of capital (WACC)
n = Explicit forecast period (typically 5-10 years)
Terminal = FCF_n * (1 + g) / (r - g)
g = Perpetual growth rate (never exceed 3% for China)
Zhang's practical guidelines for DCF:
| Parameter | Conservative Default | Notes |
|---|---|---|
| Forecast period | 5 years | 10 years only for extremely stable |
| Discount rate (WACC) | 10-12% | Higher for cyclicals, smaller caps |
| Terminal growth rate | 0-3% | Default to GDP growth or below |
| FCF calculation | NOPAT - Net CapEx | Use maintenance CapEx, not total |
| Revenue growth | Industry avg or below | Never assume acceleration |
| Margin trend | Stable or contracting | Never assume expansion |
Sensitivity check: Always run the DCF at three scenarios β base, optimistic, pessimistic. If the stock is undervalued only in the optimistic case, it is not a value investment.
Most appropriate for asset-heavy businesses β real estate, banks, holding companies, natural resource firms.
Net Asset Value (NAV):
NAV = (Fair Value of Assets) - (Total Liabilities) - (Minority Interest)
Adjustments to book value:
+ Real estate carried at historical cost -> revalue to market
+ Investment securities at cost -> revalue to market
+ Inventory at FIFO in inflationary env -> adjust to replacement cost
- Goodwill from overpriced acquisitions -> write down to zero
- Intangibles with no separable value -> write down to zero
- Off-balance-sheet liabilities -> add back (guarantees, leases)
Liquidation Value (floor price):
Liquidation Value = Cash + (0.75 * Receivables) + (0.50 * Inventory)
+ (0.30 * PP&E) - Total Liabilities
Rule: If market cap < Liquidation Value, strong buy signal.
The workhorse method for most operating companies.
Normalized Earnings:
Normalized EPS = Average of (EPS over a full business cycle, typically 5-7 years)
Adjustments:
- Remove one-time gains/losses
- Remove asset impairments (add back if recurring write-downs mask true earnings)
- Adjust for stock-based compensation expense
- Adjust for cyclical peak/trough (use mid-cycle margin)
Earnings Power Value (EPV):
EPV = (Normalized EBIT * (1 - Tax Rate)) / WACC
If EPV > Asset Value -> franchise value exists (competitive moat)
If EPV < Asset Value -> management is destroying value (red flag)
P/E-Based Fair Value:
Fair Value = Normalized EPS * Justified P/E
Justified P/E depends on:
- Growth rate: higher growth -> higher P/E
- ROE: higher ROE -> higher P/E
- Payout ratio: higher payout -> higher P/E (if ROE < cost of equity)
- Risk: lower risk -> higher P/E
Zhang's P/E guidelines for A-shares:
Low growth, low moat : 8-12x
Moderate growth, some moat: 12-18x
High growth, strong moat : 18-25x
Exceptional franchise : 25-35x (rare; must justify individually)
Used as a sanity check, never as the primary method.
Peer comparison framework:
Step 1: Identify 5-8 direct competitors (same industry, similar scale)
Step 2: Calculate key multiples for each:
- P/E (trailing, forward, normalized)
- P/B
- EV/EBITDA
- P/FCF
Step 3: Rank the target vs. peers on quality metrics:
- ROE, ROIC
- Revenue growth (3-year CAGR)
- Margin stability
- Balance sheet strength (D/E)
Step 4: Target deserves a premium/discount to peer median based on
quality ranking
Historical valuation band:
Plot the stock's P/E (or P/B) over the past 10 years.
Identify the median, 25th percentile, and 75th percentile.
Below 25th percentile -> potentially undervalued (investigate)
Near median -> fairly valued (no action)
Above 75th percentile -> potentially overvalued (consider selling)
Warning: Historical multiples are only meaningful if the business has
not fundamentally changed. A declining business deserves lower multiples
than its own history.
Final Intrinsic Value Range = Intersection of:
1. DCF valuation range (pessimistic to base case)
2. Asset-based floor
3. Earnings power value
4. Comparative valuation implied range
If methods diverge widely (>50% spread), the investment is too uncertain
to act on. Move to the next candidate.
If methods converge within a 20-30% range, take the conservative end
as the working estimate of intrinsic value.
Zhang devotes extensive attention to reading financial statements with a skeptical, forensic eye. The goal is not to accept reported numbers at face value but to reconstruct the economic reality of the business.
Revenue quality checklist:
| Check | Red Flag |
|---|---|
| Revenue growth vs. industry | Far exceeds industry without clear reason |
| Revenue concentration | Top 5 customers > 50% of revenue |
| Channel stuffing signals | Q4 revenue spike with Q1 returns/reversals |
| Related-party revenue | > 10% from related parties |
| Revenue recognition policy | Aggressive (bill-and-hold, percentage-of-completion abuse) |
Margin analysis:
Gross margin trend over 5 years:
Stable or improving -> pricing power, good sign
Declining -> competitive pressure, investigate
Operating margin vs. gross margin:
Widening gap -> SGA bloat, losing operating leverage
Narrowing gap -> improving efficiency
Net margin vs. operating margin:
Large gap -> heavy interest burden or one-time items
Asset quality scorecard:
Cash and equivalents : Verify with cash flow statement (if cash is high
but operating cash flow is low, cash may be restricted)
Receivables / Revenue : Should be stable or declining; rising ratio = collection risk
Inventory / COGS : Rising ratio = potential obsolescence or demand weakness
Goodwill / Total Assets : > 30% is dangerous; impairment risk
PP&E age : (Accumulated Depreciation / Gross PP&E) > 70% means
aging assets, future CapEx cliff ahead
Liability warning signs:
Short-term debt / Total debt > 60% -> refinancing risk
Interest coverage (EBIT / Interest) < 3x -> financial distress risk
Off-balance-sheet guarantees -> hidden liabilities
Contingent liabilities in footnotes -> lawsuit / regulatory risk
Zhang considers the cash flow statement the single most important financial document because it is the hardest to manipulate.
Cash flow quality framework:
Operating Cash Flow / Net Income (over 3 years):
> 1.0 -> earnings are backed by cash (high quality)
0.7-1.0 -> acceptable, investigate working capital changes
< 0.7 -> earnings may be paper profits (red flag)
Free Cash Flow = Operating CF - Maintenance CapEx
Positive and growing -> business generates real economic value
Negative for 3+ years -> business is a cash consumer (avoid unless turnaround)
CapEx classification:
Maintenance CapEx = Depreciation (approximation)
Growth CapEx = Total CapEx - Maintenance CapEx
If company claims most CapEx is "growth" but revenue is stagnant,
management is either lying or incompetent.
Zhang compiles a list of accounting manipulations common in A-share companies:
Rule: If any two of the five red flags appear simultaneously, eliminate the company from consideration regardless of how cheap it looks.
Zhang argues that industry selection is half the battle. Even the best company in a terrible industry will underperform a mediocre company in a great industry.
Industry attractiveness scoring:
| Factor | Weight | Scoring (1-5) |
|---|---|---|
| Industry growth rate | 20% | 5 = >15% CAGR, 1 = declining |
| Competitive concentration | 20% | 5 = oligopoly, 1 = fragmented commodity |
| Barriers to entry | 20% | 5 = insurmountable, 1 = none |
| Regulatory stability | 15% | 5 = supportive/stable, 1 = hostile/uncertain |
| Cyclicality | 15% | 5 = non-cyclical, 1 = highly cyclical |
| Capital intensity | 10% | 5 = asset-light, 1 = extremely capital-heavy |
Threshold: Weighted score >= 3.5 to proceed with company-level analysis.
Zhang adapts the Buffett/Morningstar moat framework for Chinese market conditions:
Moat types (ranked by durability in China):
1. Government licenses / concessions (strongest in China's regulated economy)
2. Network effects (internet platforms, payment systems)
3. Switching costs (enterprise software, banking relationships)
4. Brand and reputation (consumer staples, luxury, baijiu)
5. Cost advantages / economies of scale (manufacturing, logistics)
6. Patents / intellectual property (weakest in China due to enforcement gaps)
Moat evidence checklist:
[ ] Stable or rising market share over 5+ years
[ ] Gross margins > industry average by 5+ percentage points
[ ] ROE consistently > 15% without excessive leverage
[ ] Pricing power demonstrated during at least one economic downturn
[ ] Customer retention rate > 85% (where measurable)
[ ] Competitors have tried and failed to replicate the advantage
Zhang modifies Porter's framework for the A-share context by adding a sixth force: Government policy risk, which in China can override all five traditional forces overnight (e.g., tutoring industry crackdown, internet platform regulation).
Margin of safety is the gap between estimated intrinsic value and the purchase price. It serves two functions simultaneously:
Zhang prescribes different minimum discounts based on the quality and certainty of the investment:
| Company Quality | Minimum Discount to Intrinsic Value | Rationale |
|---|---|---|
| Exceptional franchise | >= 20% | High certainty of value |
| Strong business, some risk | >= 30% | Standard requirement |
| Average business, cheap | >= 40% | Greater estimation error |
| Turnaround / special sit | >= 50% | Binary outcome risk |
| Cyclical at trough | >= 40% off mid-cycle value | Timing uncertainty |
Margin of Safety (%) = (Intrinsic Value - Current Price) / Intrinsic Value * 100
Example:
Intrinsic Value estimate = 25.00 RMB
Current market price = 17.50 RMB
Margin of Safety = (25.00 - 17.50) / 25.00 = 30%
For a strong business (30% required), this just meets the threshold.
Therefore, Zhang recommends using the upper end of the margin of safety range for most A-share investments.
A stock can be undervalued indefinitely. Without a catalyst β an identifiable event or process that will cause the market to recognize the value β capital remains trapped. Zhang insists that every investment thesis must include at least one credible catalyst.
Hard catalysts (specific, time-bound events):
- Earnings surprise: Company about to report a significant beat
- Asset sale / spinoff: Unlocking hidden value in a conglomerate
- Buyback announcement: Management signaling undervaluation with capital
- Dividend increase: Forces market to re-rate the stock's yield
- Regulatory approval: New product/license approval pending
- Activist involvement: Large shareholder pushing for change
- Index inclusion: Forced buying from passive funds (MSCI, CSI)
- Insider buying: Management purchasing shares on open market
Soft catalysts (gradual, process-driven):
- Industry consolidation: Weaker competitors exiting, share gains accelerating
- Margin expansion: Raw material costs declining, pricing power improving
- Debt reduction: Deleveraging improving equity value and reducing risk
- Management change: New CEO implementing operational improvements
- Market sentiment shift: Sector rotation toward value / quality
- Institutional discovery: Under-covered stock beginning to attract analyst coverage
For each identified catalyst, assess:
1. Probability of occurrence (High / Medium / Low)
2. Magnitude of impact on value (>20% / 10-20% / <10%)
3. Time horizon (< 6 months / 6-18 months / > 18 months)
Minimum requirement:
At least one catalyst with High probability AND >10% impact
within 18 months, OR
At least two catalysts with Medium probability AND >10% impact
within 12 months.
If no credible catalyst exists, the stock goes on the watchlist but
is NOT purchased, regardless of discount.
ALL of the following must be satisfied before buying:
1. VALUATION: Margin of safety meets or exceeds the required minimum
for the company's quality tier.
2. CATALYST: At least one credible catalyst identified per Section 7.3.
3. QUALITY: No more than one financial red flag from Section 4.4.
4. INDUSTRY: Industry attractiveness score >= 3.5 (Section 5.1).
5. PORTFOLIO FIT: Position does not violate any portfolio construction
rules (Section 10).
6. LIQUIDITY: Average daily trading volume > 10M RMB (can build/exit
full position within 10 trading days).
Position Size = f(Conviction, Margin of Safety, Portfolio Concentration)
Conviction levels:
HIGH (all valuation methods converge, multiple catalysts, strong moat)
-> 6-10% of portfolio
MEDIUM (most methods agree, one clear catalyst, decent moat)
-> 3-6% of portfolio
LOW (attractive but some uncertainty remains)
-> 1-3% of portfolio
Initial purchase: 50% of intended full position
Scaling plan: Add remaining 50% if price declines a further 10-15%
or thesis strengthens with new information
Preferred entry conditions (not required, but improve outcomes):
- Market sentiment indicator in "fear" zone (e.g., high VIX equivalent,
low margin lending balance, media pessimism)
- Stock at or near 52-week low
- Volume declining (selling exhaustion)
- Technical support level nearby (limits near-term downside)
Avoid buying:
- Immediately before earnings announcement (uncertainty premium)
- During heavy insider selling periods
- When the broader market is in a euphoric phase (everything looks cheap
relative to momentum stocks, but nothing is actually cheap in absolute terms)
PRIMARY EXIT: Price reaches or exceeds estimated intrinsic value.
Procedure:
1. When price is within 10% of intrinsic value, begin reducing position
(sell 30-50% of holdings).
2. When price reaches intrinsic value, sell another 30%.
3. Hold final 20% as a "free option" β sell only if price exceeds
intrinsic value by 20% or a new (lower) estimate of value is reached.
DEFENSIVE EXIT: Original investment thesis is invalidated.
Thesis-breaking events (sell immediately, regardless of loss):
- Accounting fraud discovered or strongly suspected
- Competitive moat permanently impaired (new disruptive competitor,
regulatory change destroying the business model)
- Management integrity failure (insider trading, self-dealing, fraud)
- Permanent impairment of earning power (not a cyclical downturn)
- Debt covenant breach or liquidity crisis with no resolution path
UPGRADE EXIT: Sell a position with lower expected return to fund a
position with significantly higher expected return.
Requirements:
- New opportunity must offer >= 50% more upside than the position
being sold
- New opportunity must meet all entry criteria (Section 8.1)
- Transaction costs and tax implications must be factored in
- Do not swap positions for marginal improvements (<20% better)
If a position has not moved toward intrinsic value within 24 months
AND no new catalyst has emerged:
- Re-evaluate the entire thesis from scratch
- If thesis still intact and margin of safety still exists, reset
the 24-month clock
- If thesis is weakening or opportunity cost is high, exit and
redeploy capital
Zhang's rule: "Dead money is the silent killer of returns."
Zhang advocates concentrated portfolios. Diversification beyond a point dilutes the value investor's edge β the ability to know a few businesses deeply.
Optimal portfolio: 8-15 positions
- Minimum position: 2% (below this, it cannot meaningfully impact returns)
- Maximum position: 12% at cost (15% if appreciated)
- Top 5 positions: 50-65% of portfolio
Sector limits:
- No single sector > 30% of portfolio
- At least 4 different sectors represented
Style balance:
- Mix deep value (asset-heavy, low P/B) with quality value
(high ROE, moderate P/E) to reduce style concentration risk
Market cap:
- Large cap (>50B RMB): 40-60%
- Mid cap (10-50B RMB): 30-40%
- Small cap (<10B RMB): 0-20%
Cyclical exposure:
- Cyclical stocks (materials, energy, industrials): Max 30%
- Defensive stocks (consumer staples, utilities, healthcare): Min 30%
Minimum cash reserve: 10% (always available for unexpected opportunities)
Maximum cash: 40% (beyond this, you are a market timer, not a value investor)
Raise cash:
- When few opportunities meet margin of safety requirements
- When market-wide P/E exceeds 25x trailing or 20x forward
Deploy cash:
- When broad market correction creates multiple opportunities
- When individual stocks hit entry criteria even in normal markets
"Cash is a residual of the opportunity set, not a directional bet
on the market."
Zhang categorizes risk into three layers, each requiring different management:
| Risk Layer | Examples | Management Approach |
|---|---|---|
| Company risk | Earnings miss, fraud, management failure | Deep research, margin of safety |
| Industry risk | Disruption, regulation, commodity collapse | Sector diversification |
| Market/Macro risk | Bear market, liquidity crisis, currency | Cash reserves, position sizing |
Stop-loss rule: Zhang does NOT use mechanical stop-losses.
Instead, he uses a "thesis monitor":
- If price drops 20% after purchase, mandatory re-analysis of thesis
- If thesis holds AND margin of safety has increased, consider adding
- If thesis is weakening, reduce by 50%
- If thesis is broken, exit entirely
Maximum loss per position: Accept up to 30% loss on any single holding
before serious portfolio damage occurs (given max 12% position size,
worst case = 3.6% portfolio impact).
Maximum drawdown tolerance: 20% from peak portfolio value
- At -10%, review all positions; trim weakest thesis holdings
- At -15%, raise cash to 25% minimum; only hold highest conviction
- At -20%, invoke full defensive protocol: 40% cash, only hold
positions with > 40% margin of safety
Correlation monitoring:
- If correlation among top 5 holdings exceeds 0.7 during stress
periods, the portfolio is insufficiently diversified. Reduce
exposure to the most correlated names.
Before every purchase, Zhang requires the investor to write a one-page "pre-mortem":
Assume the investment has lost 50% of its value in 18 months.
Write the story of what went wrong.
Purpose:
- Forces identification of risks you might otherwise ignore
- Reveals hidden assumptions in the thesis
- If the pre-mortem story feels plausible and probable, do not invest
- If the pre-mortem requires a chain of unlikely events, proceed
Zhang identifies impatience as the single greatest destroyer of value investing returns.
Patience rules:
1. WAIT FOR THE PITCH: Do not invest merely because you have cash. The value
investor's job is to wait for a fat pitch β an obvious mispricing with a
clear catalyst. Most of the time, the correct action is no action.
2. HOLD THROUGH NOISE: Once purchased, ignore daily price fluctuations.
Check the thesis quarterly, not the price daily. The market is a voting
machine in the short term and a weighing machine in the long term.
3. ACCEPT DEAD PERIODS: Months or even years may pass without a single
actionable opportunity. This is normal and healthy. The compounding happens
in bursts when great opportunities appear and you are prepared.
The value investor must be psychologically comfortable:
- Buying what others are selling (and selling what others want)
- Holding positions that have declined 20-30% if the thesis is intact
- Owning "ugly" companies that nobody wants to discuss at dinner parties
- Being wrong in the short term (and appearing foolish) while being
right over the full cycle
Zhang's test: "If buying this stock does not make you at least slightly
uncomfortable, it probably is not cheap enough."
Before every trade, answer these questions:
1. Am I buying/selling based on analysis or emotion?
2. Would I make this trade if the market were closed for 3 years?
3. Am I anchoring to my purchase price or evaluating current value?
4. Am I acting because something changed, or because I am bored/anxious?
5. Have I written down my thesis, and has it actually been invalidated?
If any answer suggests emotional decision-making, do NOT execute the trade.
Wait 48 hours and re-evaluate.
Zhang requires maintaining a written journal for every position:
Entry journal:
- Date and price
- Intrinsic value estimate (with methodology)
- Margin of safety percentage
- Identified catalysts and expected timeline
- Pre-mortem scenario
- Explicit exit criteria (price targets and thesis-break conditions)
Ongoing journal (quarterly):
- Has the thesis changed? How?
- Has intrinsic value estimate changed? Why?
- Has the catalyst materialized or been delayed?
- Am I still comfortable holding?
Exit journal:
- Date and price
- Return (absolute and annualized)
- Was the thesis correct? Where was it wrong?
- Lessons learned for future investments
A value trap is a stock that appears cheap on traditional valuation metrics but is cheap for a good reason β the business is permanently impaired, and the "cheapness" is actually a fair reflection of deteriorating fundamentals.
1. DECLINING INDUSTRY LEADER
Symptoms: Low P/E, high dividend yield, strong brand
Reality: Industry is in secular decline; earnings are shrinking
Example: Traditional print media, declining commodity producers
2. FINANCIAL ENGINEERING
Symptoms: Low P/E boosted by share buybacks funded with debt
Reality: Underlying business is stagnant; leverage is rising
Test: Remove buyback impact β is EPS still growing?
3. CYCLICAL PEAK EARNINGS
Symptoms: Low P/E at the top of the business cycle
Reality: Earnings are about to collapse; the "cheap" P/E is
based on peak earnings that are not sustainable
Test: Use normalized (mid-cycle) earnings, not trailing
4. ACCOUNTING MIRAGE
Symptoms: Low P/E, but operating cash flow < 70% of net income
Reality: Earnings are being manufactured through aggressive
accounting; real profitability is far lower
Test: Value on cash flow, not reported earnings
5. GOVERNANCE DISCOUNT
Symptoms: Low valuation, controlling shareholder with >50% stake
Reality: Controlling shareholder extracts value through related-
party transactions, excessive compensation, or tunneling
Test: Track related-party transactions as % of revenue
6. PERPETUAL TURNAROUND
Symptoms: Low P/B, new management promises "transformation"
Reality: Turnaround has been promised for years with no results;
each new plan consumes more capital
Test: Has ROE improved over the last 3 years? If not, skip.
7. POLICY VICTIM
Symptoms: Suddenly cheap after a regulatory crackdown
Reality: The business model has been permanently impaired by
government action; the old earnings power is gone forever
Test: Can the company earn reasonable returns under the
new regulatory regime? If not, no price is cheap enough.
Score one point for each "yes":
[ ] Revenue declining for 2+ consecutive years
[ ] Market share losses documented
[ ] ROE trending down over 5 years
[ ] OCF/NI ratio < 0.7 for 3+ years
[ ] Increasing debt without corresponding asset/revenue growth
[ ] Multiple management changes in 5 years
[ ] Industry facing structural disruption
[ ] Controlling shareholder extracting value
Score:
0-1: Unlikely value trap (proceed with analysis)
2-3: Caution (investigate each flag deeply before proceeding)
4+: Probable value trap (eliminate from consideration)
Stage 1: Screening
Company: "Precision Manufacturing Co." (hypothetical)
Ticker: Screened from a universe of 4,000+ A-share stocks
Filters passed:
- P/E (normalized) = 9.5x (< 12x threshold)
- P/B = 1.1x (< 1.5x threshold)
- ROE (3-year avg) = 16.2% (> 15% threshold)
- D/E ratio = 0.35 (< 0.5 threshold)
- OCF/NI ratio = 1.08 (> 1.0 threshold)
- Dividend yield = 4.2% (> 3% threshold)
- Market cap = 15B RMB (mid-cap)
Stage 2: Deep Analysis
Business: Leading manufacturer of precision components for the
automotive and industrial automation sectors. #2 market share in
China, #5 globally.
Competitive moat: Cost advantage (30% lower labor + energy vs. European
competitors) combined with improving quality that is closing the gap
with Japanese peers.
Financial health:
- Revenue CAGR (5yr): 12%
- Gross margin: 28% (stable)
- Net margin: 11% (stable)
- FCF positive in 4 of last 5 years
- Cash position: 2.5B RMB (no net debt)
- No accounting red flags detected
Management: Founder-CEO with 22% personal stake. Aligned incentives.
Conservative capital allocation history. No related-party concerns.
Stage 3: Valuation
Method 1: DCF
Assumptions: 10% revenue growth x 5 years, 10.5% WACC, 2% terminal growth
Result: 22.80 RMB per share
Method 2: Earnings Power Value
Normalized EBIT: 2.1B RMB, Tax rate: 25%, WACC: 10.5%
EPV = (2.1B * 0.75) / 0.105 = 15.0B -> 21.40 RMB per share
Method 3: Asset-based
Adjusted NAV (revaluing factory land to market): 14.20 RMB per share
Method 4: Comparative
Peer average P/E: 14x; at 14x normalized EPS -> 20.30 RMB per share
Triangulated intrinsic value range: 20.30 - 22.80 RMB
Conservative estimate: 20.30 RMB
Stage 4: Margin of Safety Assessment
Current price: 13.70 RMB
Intrinsic value (conservative): 20.30 RMB
Margin of safety: (20.30 - 13.70) / 20.30 = 32.5%
Required margin for "strong business, some risk": 30%
Result: PASSES (32.5% > 30%)
Stage 5: Catalyst Identification
Catalyst 1: Auto industry recovery (probability: HIGH, impact: >20%,
timeline: 6-12 months). Auto sales have been declining for 18 months;
government stimulus for EV purchases announced.
Catalyst 2: European competitor restructuring (probability: MEDIUM,
impact: 10-20%, timeline: 12-18 months). Major German competitor
announced plant closures; market share available for capture.
Assessment: Meets catalyst requirements (one HIGH probability catalyst).
Stage 6: Entry Execution
Conviction: HIGH (valuation convergence, strong catalyst, solid moat)
Target position: 7% of portfolio
Initial purchase: 3.5% at 13.70 RMB (50% of full size)
Scale-in plan: Add 3.5% if price drops to 12.30 RMB (-10%)
Stage 7: Monitoring (Months 1-18)
Month 3: Price = 12.80 (-6.6%). Auto sales data still weak. Thesis intact.
Added remaining 3.5% position. Average cost: 13.25 RMB.
Month 6: Price = 13.10. Auto sales bottoming. Q2 earnings in line.
No action required.
Month 9: Price = 15.40. Auto sales recovering. Analyst coverage initiated
by two brokerages. Thesis progressing.
Month 12: Price = 18.20. Strong earnings beat. European competitor exited
one product line. Market recognizing value.
Month 15: Price = 19.50. Approaching intrinsic value estimate.
Sold 40% of position at 19.50.
Month 18: Price = 21.80. Exceeds conservative IV estimate.
Updated IV (reflecting better-than-expected share gains): 24.00.
Sold 40% at 21.80. Holding final 20% as "free option."
Stage 8: Exit and Review
Final exit: Sold remaining shares at 23.50 (month 22) when P/E reached
18x normalized β above fair value range.
Returns:
Average purchase price: 13.25 RMB
Average selling price: 20.95 RMB (blended across three sales)
Holding period return: 58.1%
Annualized return: 30.4% (over ~22 months)
Post-mortem:
+ Valuation discipline worked β bought with adequate margin of safety
+ Catalyst thesis was correct β auto recovery drove re-rating
+ Scaling in improved average cost by ~3%
- Could have been more patient on exit; stock ran to 24.50 eventually
- Lesson: Accept leaving some upside on the table; it is the cost of
discipline
Zhang Jingdong distills the entire value discovery process into a set of guiding principles that the practitioner should internalize:
1. Price is what you pay; value is what you get. Never confuse a low price with a good investment. The only thing that matters is the relationship between price and intrinsic value.
2. The margin of safety is non-negotiable. It is the seat belt of investing. You do not decide whether to wear it based on traffic conditions. You wear it every single time.
3. Cash flow is truth; earnings are opinion. A business that reports profits but generates no cash is not a profitable business. Always verify earnings quality through the cash flow statement.
4. The best time to buy is when you least want to. True bargains emerge when fear is pervasive, news is terrible, and buying feels physically uncomfortable. If it feels easy, you are probably too late.
5. You cannot value what you do not understand. Never invest in a business whose economics you cannot explain in plain language. If the thesis requires a spreadsheet with 50 assumptions, you do not understand it well enough.
6. A catalyst is the bridge between value and price. Undervaluation without a catalyst is a theory. Undervaluation with a catalyst is an investment.
7. Value traps are more dangerous than missed opportunities. Losing 50% on a value trap requires a 100% gain to recover. Missing a stock that doubles costs you nothing. Err on the side of skepticism.
8. Patience is a competitive advantage. Most investors are structurally incapable of waiting. Quarterly performance pressure, career risk, and boredom force them to act. The individual value investor who can wait 2-3 years for a thesis to play out has an edge that no algorithm can replicate.
9. Write it down. An investment thesis that lives only in your head will shift and rationalize with every price move. Written convictions create accountability and expose sloppy thinking.
10. The process matters more than any single outcome. A correct process will sometimes produce losses; a flawed process will sometimes produce gains. Over hundreds of decisions, only the process compounds. Judge yourself by the quality of your analysis, not by the randomness of outcomes.
11. Diversification is an admission of ignorance β and that is fine. Hold enough positions that no single mistake is fatal, but few enough that each position reflects genuine conviction and deep knowledge.
12. The market is a servant, not a master. The market offers you prices every day. You are free to accept or ignore them. Never let the market's opinion of a stock become your opinion of the business.
End of implementation specification.